Eli Lilly and Company (LLY)
Last Price$746.2(4.9%)
Market Cap$907.2B
LLY overview
Crunching data... Almost there!
1W (10.1%)
1M (18.2%)
6M (4.9%)
YTD 26.8%
1Y 27.6%
3Y 197.5%
5Y 603.4%
10Y 1,241.6%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
LLY key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
LLY Intrinsic value
LLY Intrinsic value overview
LLY Historical intrinsic value
LLY Financials
LLY Income statement
Crunching data... Almost there!
LLY Balance sheet
Crunching data... Almost there!
LLY Cash flow statement
Crunching data... Almost there!
LLY Financial ratios
LLY Growth
Crunching data... Almost there!
LLY Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more LLY fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Eli Lilly and Company (LLY) stock?
As of today, intrinsic value of Eli Lilly and Company is $462.7.
Is Eli Lilly and Company (LLY) stock undervalued or overvalued?
As of today, Eli Lilly and Company is overvalued by 38.0%, compared to the current market share price of $746.2.
What is Eli Lilly and Company (LLY) stock rating?
As of today, Eli Lilly and Company has a stock rating of 4 (out of 10), which is considered Good.
is Eli Lilly and Company (LLY) a good stock to buy?
As of today, Eli Lilly and Company has a Good stock rating, which is 38.0% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.